Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients.
about
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patientsThe role of total mesorectal excision in the management of rectal cancerSphincter preservation after short-term preoperative radiotherapy for low rectal cancer--presentation of own data and a literature review.Preoperative diagnosis and staging of rectal cancer using diffusion-weighted and water imaging combined with dynamic contrast-enhanced scanning.Should urologists be spending more time on the golf course?Dramatic innovations in modern surgical subspecialtiesCurrent status of total mesorectal excision and autonomic nerve preservation in rectal cancer.Role of the surgeon as a variable in the treatment of rectal cancer.The emerging role of neoadjuvant chemotherapy for rectal cancerManagement of primary rectal cancer by surgeons in Atlantic Canada: results of a regional survey.Prognostic value of serum soluble Fas in patients with locally advanced unresectable rectal cancer receiving concurrent chemoradiotherapyIs laparoscopic colorectal cancer surgery equal to open surgery? An evidence based perspective.Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients.Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades.Long-term Outcomes of Laparoscopic Surgery for Colorectal Cancer.Recent advances in the pharmacological treatment of colorectal cancer.Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer.Peri-operative radiotherapy for rectal cancer: the case for a selective pre-operative approach - the third way.Adjuvant therapy for rectal cancer--the transatlantic view.Prognostic implication of metastatic lymph node ratio in node-positive rectal cancer.Management of colorectal cancers.Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer.Pre-operative radiotherapy for rectal carcinoma? Has the case really been made for short course pre-operative radiotherapy if surgical standards for rectal carcinoma are optimal?Laparoscopic total mesorectal excision for rectal cancer surgery.Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors.Total adventitial resection of the cardia: 'optimal local resection' for tumours of the oesophagogastric junctionMRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?Role of radiation therapy in neoadjuvant era in patients with locally advanced rectal cancerNeoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer.Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancerCurrent surgical management of rectal cancer.Post operative stereotactic radiosurgery for positive or close margins after preoperative chemoradiation and surgery for rectal cancerRectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging.Advances in minimally invasive surgery in the treatment of colorectal cancer.Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume centerLaparoscopic total mesorectal excision for rectal cancer: experience of a single center with a series of 174 patients.Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview.MicroRNAs: relevant tools for a colorectal surgeon?Follow-up after curative resection of colorectal cancer.The evolution of cancer surgery and future perspectives.
P2860
Q24569637-3A83E5BE-1157-49DC-ACB7-08A1ABA2E82BQ28177705-33A12A31-7BF1-4CC5-978A-49D835EBA306Q30663628-F3BA0865-D0E8-4B7D-8FE8-9E8D548F6BB8Q30865920-E3003CD4-D7C3-45C3-A041-5C009443EB01Q33281552-E8BAAD33-30B0-4AE8-9188-896EB13F8685Q34161700-4A30C7F2-9FD6-4D9A-A714-48D38998DB1EQ34176685-C5FFAE0E-0349-41AD-A26A-310A2E9C5DC2Q34176692-FC423753-F506-4480-8D08-8D39ECCC90B2Q34234935-61DDF43C-FF12-4798-B3E3-7F33C911CCD8Q34356749-EF4FEDD2-1F35-47AC-AF45-5072AF03817EQ34381899-230CABA6-A07B-490F-A38A-30D3D4055900Q34391337-DACA9886-8C3A-4582-95C0-AE2E505E4579Q34437609-D0773B97-A0AC-43A7-BE2F-CC51A4191ED6Q34537462-00B2A630-5848-42E0-8258-D7725D2EDCFCQ34971228-B00020B4-C1B8-462C-B4CB-FF7FF8CBA8EEQ35073360-FAFD0676-AC2F-479B-94A6-EA45E22260D9Q35128016-02ACC08D-2A50-419B-867B-7DB8C6B052FEQ35157528-FB7C1479-12AA-402F-9377-35BE1201B97FQ35202155-459B9E5A-A8CC-45CC-81C7-E4448A87CED8Q35483162-430A7207-E8E7-4B33-8ED6-8D3D088E83C0Q35527086-9D8142DF-926A-4FAE-8941-6075DA9DF780Q35542484-82D3EDAB-E31A-4CD6-AE55-A65F397453FCQ35615010-2E42992C-0B69-4733-80AE-B8A8E1862E01Q36341306-D42707C2-BDE8-4451-8628-2775630ECA5EQ36349876-7DBDE1F9-1A11-41D0-82CD-E92E994D1493Q36593709-870B598B-B665-43B6-B45C-913F917C80EBQ36613720-79E31C05-F84C-4453-8227-7A1E3F4180B4Q36637126-C0CD522D-F096-4E72-9531-5BAF51E94103Q36646705-7A0F1FA1-87BB-4105-AB9F-E4E421969B17Q36772469-EB589A92-7BFD-41FF-B62F-C0FABE1A4127Q36796766-DD129CF2-AA25-40FE-A2A5-ACF08B10AF74Q36937011-2C326484-EDC6-4111-98A9-33DE0DACC2BEQ37034524-2A444E14-5FF3-4766-920A-8054B59C8CB2Q37038918-5F278FC7-5567-4451-A391-C639E0AF730DQ37235053-DD3EF709-D55A-49D9-AAED-D0AA574F41E8Q37770459-8DF5A769-8496-4786-A3E9-E4BDB72F3FCAQ37878381-7B0C5EAF-45CF-4F80-9019-49A8892E963EQ38004774-900D2C78-8AAF-4ECE-B407-37E516E9F9FFQ38165750-60812F22-DF9F-4619-9CDF-CC1D8FBD815BQ38266722-E543BF92-E20C-4D5D-BAC5-25EE02E34404
P2860
Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Improved survival and local co ...... nal analysis of 1411 patients.
@en
Improved survival and local co ...... nal analysis of 1411 patients.
@nl
type
label
Improved survival and local co ...... nal analysis of 1411 patients.
@en
Improved survival and local co ...... nal analysis of 1411 patients.
@nl
prefLabel
Improved survival and local co ...... nal analysis of 1411 patients.
@en
Improved survival and local co ...... nal analysis of 1411 patients.
@nl
P2093
P356
P1476
Improved survival and local co ...... nal analysis of 1411 patients.
@en
P2093
Norstein J
van Houwelingen HC
van de Velde CJ
P304
P356
10.1053/EJSO.1999.0659
P577
1999-08-01T00:00:00Z